As revealed by the FSSAI notice [1] released on July 16th, 2020, India authorities are intensifying the surveiloption+ ferrous gluconatelance and enforcement to prohibit the manufacturing and sales, inferric gluconate ironcluding the sales on e-commerce platfout of date ferrous fumarateorms, of health supplement and nutraceutical products containing PABA (Para Amino Benzoic Acid). Any products containing such ingredient which is already emulsified ferric pyrophosphateexported to India shall be withdrawn from the market imiron ferrous sulfate near memediately.
India Strengthens Surveillance to Prohibit the Sales of Health Supplement and Nutraceutical Products Containing PABA
